Israel Active

Israel’s BrainsGate (reported briefly previously) has developed a technology for the treatment of ischemic strokes and vascular dementia. The Ischemic Stroke System is based on an implantable electrode stimulator that increases blood flow to the brain. Clinical trials are in progress.

Good to see that Israel’s six largest medical centers are using AI-based software from Israel’s Aidoc to analyze CT scans and pinpoint cerebral hemorrhage, pulmonary embolism, stroke and C-spine fractures. They are Sheba, Hadassah, Sourasky (Ichilov), Rabin, Shaare Zedek and Assuta centers.

The Car-T cancer therapy invented by Israel’s Professor Zelig Eshhar is curing thousands of blood cancer patients. But the manual effort is hugely expensive. Now Israel’s ADVA Biotechnologies is developing a simpler, automated process. More lives will be saved with less cost.

Tel Aviv University researchers have discovered a simple cure for people suffering from osteophytes (bone spurs) - lumps that grow on the heels of the feet. A 1-month controlled study of 50 patients found a 10-30 minute daily barefoot walk at home, or on a treadmill, significantly reduced pain.

Israel’s Mitrassist Medical (reported previously) has advanced to human trials of its innovative heart valve implant that avoids the risks of stopping the heart during open heart surgery. Mitrassist has just raised funds to recruit more employees and tackle additional structural heart diseases.

Israel’s PixCell Medical (reported previously) will be deploying its blood test analyzers in labs and emergency departments in New South Wales, Australia. PixCell’s HemoScreen low-cost portable hematology analyzer can perform a complete blood count at the point of care.

Hadassah hospital in Jerusalem will accept non-Covid patients from Cyprus with serious and life-threatening medical conditions to relieve local hospitals under strain from Covid-19. Hadassah also wants to build a hospital complex and rehabilitation center in Cyprus.

Nice article in TravelTrend about how the SonoMask facemasks from Israel’s Sonovia (reported previously) protect their wearers and the public against the coronavirus.

Israeli-founded Canadian-based RetiSpec has developed the RS1, which uses hyperspectral retinal imaging and AI to examine the back of the eye. It can identify harmful amyloid proteins and other evidence that indicate Alzheimer’s Disease, even before the patient shows symptoms.

Israel’s Derma Detect has developed an algorithm and AI applications for analyzing digital images to detect, treat, and manage non-pigmented skin lesions. The company’s platform analyzes images of the skin using deep learning and computer vision. Currently being trialed in Israel.